Business Context and Reporting Period
This Form 8-K filing by LivaNova PLC, dated April 12, 2023 (with events reported through April 21, 2023), addresses executive leadership changes. Specifically, it details the formalization of compensation arrangements for William A. Kozy, who was appointed interim Chief Executive Officer (CEO) on April 14, 2023.
Key Financial Metrics
This filing does not contain operational financial results such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation terms.
Material Changes
The primary material change is the appointment of William A. Kozy as interim CEO and the subsequent execution of an offer letter on April 19, 2023. Key terms include:
- Role Transition: Mr. Kozy transitions from Chair of the Board to interim CEO, waiving director fees and standard equity awards associated with his non-executive director role.
- Employment Term: The term commenced April 14, 2023, and continues until the earlier of a successor's appointment or the six-month anniversary, with a Board option to extend to 12 months.
- Compensation Structure:
- Base Salary: $975,000 annually.
- Performance Bonus: Target of 110% of base salary, pro-rated based on days employed and company performance.
- Equity Award: A one-time grant of time-based restricted stock units (RSUs) with a grant date value of $500,000, vesting on the six-month anniversary of the start date.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business performance. It notes that Mr. Kozy has waived standard employee benefits for U.S. employees but is entitled to tax advice and immigration support for business travel to the United Kingdom. No specific risks or contingencies regarding the company's operations are disclosed in this report.
Investor Verification Checklist
- Verify the exact vesting schedule and conditions for the $500,000 RSU grant.
- Confirm the specific performance metrics used to calculate the 110% target bonus.
- Monitor future filings for the appointment of a permanent CEO to determine the actual duration of the interim term.
- Review the impact of the waiver of director fees on the total compensation expense for the Board.